177 related articles for article (PubMed ID: 30420329)
1. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT).
Itoh T; Tamura K; Ueda H; Tanaka T; Sato K; Kuroda R; Aoki S
Bioorg Med Chem; 2018 Dec; 26(22):5922-5933. PubMed ID: 30420329
[TBL] [Abstract][Full Text] [Related]
2. Diastereoselective Synthesis of the Borylated d-Galactose Monosaccharide 3-Boronic-3-Deoxy-d-Galactose and Biological Evaluation in Glycosidase Inhibition and in Cancer for Boron Neutron Capture Therapy (BNCT).
Simone MI
Molecules; 2023 May; 28(11):. PubMed ID: 37298796
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, equilibrium, and biological study of a C-7 glucose boronic acid derivative as a potential candidate for boron neutron capture therapy.
Muz B; Azab AK; Confalonieri L; Del Grosso E; Fallarini S; Imperio D; Panza L
Bioorg Med Chem; 2022 Apr; 59():116659. PubMed ID: 35217358
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of Lipopeptide Conjugates of Mercaptoundecahydrododecaborate for Boron Neutron Capture Therapy.
Isono A; Tsuji M; Sanada Y; Matsushita A; Masunaga S; Hirayama T; Nagasawa H
ChemMedChem; 2019 Apr; 14(8):823-832. PubMed ID: 30707500
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma.
Yeh CN; Chang CW; Chung YH; Tien SW; Chen YR; Chen TW; Huang YC; Wang HE; Chou YC; Chen MH; Chiang KC; Huang WS; Yu CS
Eur J Pharm Sci; 2017 Sep; 107():217-229. PubMed ID: 28728977
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
[TBL] [Abstract][Full Text] [Related]
7. Development of theranostic active-targeting boron-containing gold nanoparticles for boron neutron capture therapy (BNCT).
Wu CY; Lin JJ; Chang WY; Hsieh CY; Wu CC; Chen HS; Hsu HJ; Yang AS; Hsu MH; Kuo WY
Colloids Surf B Biointerfaces; 2019 Nov; 183():110387. PubMed ID: 31394419
[TBL] [Abstract][Full Text] [Related]
8. Drug delivery system design and development for boron neutron capture therapy on cancer treatment.
Sherlock Huang LC; Hsieh WY; Chen JY; Huang SC; Chen JK; Hsu MH
Appl Radiat Isot; 2014 Jun; 88():89-93. PubMed ID: 24447933
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.
Asano R; Nagami A; Fukumoto Y; Miura K; Yazama F; Ito H; Sakata I; Tai A
Bioorg Med Chem Lett; 2014 Mar; 24(5):1339-43. PubMed ID: 24508130
[TBL] [Abstract][Full Text] [Related]
10. Water-Soluble
Nakagawa F; Kawashima H; Morita T; Nakamura H
Cells; 2020 Jul; 9(7):. PubMed ID: 32635272
[TBL] [Abstract][Full Text] [Related]
11. Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: a boron neutron capture therapy study.
Gifford I; Vreeland W; Grdanovska S; Burgett E; Kalinich J; Vergara V; Wang CK; Maimon E; Poster D; Al-Sheikhly M
Int J Radiat Biol; 2014 Jun; 90(6):480-5. PubMed ID: 24605770
[TBL] [Abstract][Full Text] [Related]
12. Sweet Battle of the Epimers─Continued Exploration of Monosaccharide-Derived Delivery Agents for Boron Neutron Capture Therapy.
Matović J; Bahrami K; Stockmann P; Sokka IK; Khng YC; Sarparanta M; Hey-Hawkins E; Rautio J; Ekholm FS
Mol Pharm; 2023 Jun; 20(6):3127-3139. PubMed ID: 37134022
[TBL] [Abstract][Full Text] [Related]
13. A Hypoxia-Targeted Boron Neutron Capture Therapy Agent for the Treatment of Glioma.
Luderer MJ; Muz B; de la Puente P; Chavalmane S; Kapoor V; Marcelo R; Biswas P; Thotala D; Rogers B; Azab AK
Pharm Res; 2016 Oct; 33(10):2530-9. PubMed ID: 27401411
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
[TBL] [Abstract][Full Text] [Related]
15. Advances in Boron Neutron Capture Therapy (BNCT) for Recurrent Intracranial Meningioma.
Lan TL; Lin CF; Lee YY; Lin KH; Chang FC; Lin SC; Lee JC; Chou FI; Peir JJ; Liu HM; Mu PF; Chen YW
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902408
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy of cancer: current status and future prospects.
Barth RF; Coderre JA; Vicente MG; Blue TE
Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis, and Biological Evaluation of Boron-Containing Macrocyclic Polyamines and Their Zinc(II) Complexes for Boron Neutron Capture Therapy.
Ueda H; Suzuki M; Kuroda R; Tanaka T; Aoki S
J Med Chem; 2021 Jun; 64(12):8523-8544. PubMed ID: 34077212
[TBL] [Abstract][Full Text] [Related]
19. A theranostic approach based on the use of a dual boron/Gd agent to improve the efficacy of Boron Neutron Capture Therapy in the lung cancer treatment.
Alberti D; Protti N; Toppino A; Deagostino A; Lanzardo S; Bortolussi S; Altieri S; Voena C; Chiarle R; Geninatti Crich S; Aime S
Nanomedicine; 2015 Apr; 11(3):741-50. PubMed ID: 25596074
[TBL] [Abstract][Full Text] [Related]
20. Anomeric sugar boronic acid analogues as potential agents for boron neutron capture therapy.
Imperio D; Del Grosso E; Fallarini S; Lombardi G; Panza L
Beilstein J Org Chem; 2019; 15():1355-1359. PubMed ID: 31293685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
